Maastricht Partners With Apollo – Microsoft Cardiology Consortium To Expand AI Network For Cardiology In Europe

Dr. Leonard Wee from Maastricht, Prashant Gupta from Microsoft, Dr. Sujoy Kar from Apollo present on the dais with

His Highness King Willem-Alexander of Netherlands, Dr. Harsh Vardhan, Minister of Science & Technology,

Government of India and other dignitaries from Government of Netherlands, CII and Department of Science & Technology

AICVD API to help improve cardiovascular disease prediction in the Netherlands

Dr. Leonard Wee from Maastricht, Prashant Gupta from Microsoft, Dr. Sujoy Kar from Apollo present on the dais with His Highness King Willem-Alexander of Netherlands, Dr. Harsh Vardhan, Minister of Science & Technology, Government of India and other dignitaries from Government of Netherlands, CII and Department of Science & Technology.

Maastricht University has signed an agreement with Apollo-Microsoft Cardiology Consortium to help expand the AI Network for cardiology and research on cardiovascular diseases in Netherlands. The partnership was announced at the inaugural session of the DST-CII India Netherlands Technology Summit at New Delhi recently in the presence of His Majesty Willem–Alexander, the King of the Netherlands and Mr. Harsh Vardhan, Honorable Minister for Science and Technology, Health & Family Welfare, Government of India. Her Majesty, the Queen and other ministers from the Dutch government also graced the occasion.

Apollo Hospitals–Microsoft Consortium is building AI Network for Cardiology to develop an India-specific heart risk score and better predict cardiac diseases for the general population with the help of Apollo’s database and expertise in the field, and Microsoft’s leading cloud and AI tools. The algorithm is based on a vast amount of data pooled from over 200,000 patients treated at six of Apollo’s hospitals. At Maastricht, the model will now be validated using data from the Maastricht Study (a long-term cohort health study in the Maastricht region) and from the Heart+Vascular Center at Maastricht University Medical Center.

Launched in August 2018 by Microsoft India and Apollo Hospitals, the AI-powered Cardiovascular Disease Risk Score API (application program interface) is the first-ever Intelligent Platform designed specifically to predict the risk of Cardiovascular Disease (CVD) in the Indian population. Over the past year, doctors across the Apollo network of hospitals have been successfully leveraging this AI-powered API to predict the risk of CVD and drive preventive cardiac care across the country.

The goal of the international consortium is to achieve a Standard Cardiac Risk Score. This will enable doctors across the world to identify cardiac risks in patients and design a structured road map to reduce risks, with the aim of a long-term reduction in the global burden of cardiac disease.

New Delhi, 12 November 2019